149 related articles for article (PubMed ID: 35393630)
1. A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation.
Katsuie S; Kiniwa Y; Mikoshiba A; Goto K; Okuyama R
Acta Derm Venereol; 2022 Apr; 102():adv00697. PubMed ID: 35393630
[No Abstract] [Full Text] [Related]
2. Apocrine carcinoma developing in a naevus sebaceous of scalp.
Paudel U; Jha A; Pokhrel DB; Gurung D; Parajuli S; Pant A
Kathmandu Univ Med J (KUMJ); 2012; 10(38):103-5. PubMed ID: 23132488
[TBL] [Abstract][Full Text] [Related]
3. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
Cranwell WC; Walsh M; Winship I
Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
[No Abstract] [Full Text] [Related]
4. Immunoexpression of human epidermal growth factor receptor-2 in apocrine carcinoma arising in naevus sebaceous, case report.
Tanese K; Wakabayashi A; Suzuki T; Miyakawa S
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):360-2. PubMed ID: 19703100
[No Abstract] [Full Text] [Related]
5. Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature.
Dupont A; Vergara R; Pacaud A; Dequidt L; Dutriaux C; Saunier V; Caumont C; Jullie ML; Taïeb A; Morice-Picard F; Dousset L
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1420-e1422. PubMed ID: 37458522
[No Abstract] [Full Text] [Related]
6. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
[TBL] [Abstract][Full Text] [Related]
7. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
[TBL] [Abstract][Full Text] [Related]
8. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
[TBL] [Abstract][Full Text] [Related]
9. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
10. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
[No Abstract] [Full Text] [Related]
11. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopy of tumours arising in naevus sebaceous: a morphological study of 58 cases.
Zaballos P; Serrano P; Flores G; Bañuls J; Thomas L; Llambrich A; Castro E; Lallas A; Argenziano G; Zalaudek I; del Pozo LJ; Landi C; Malvehy J
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2231-7. PubMed ID: 26300536
[TBL] [Abstract][Full Text] [Related]
13. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
Levinsohn JL; Tian LC; Boyden LM; McNiff JM; Narayan D; Loring ES; Yun D; Sugarman JL; Overton JD; Mane SM; Lifton RP; Paller AS; Wagner AM; Antaya RJ; Choate KA
J Invest Dermatol; 2013 Mar; 133(3):827-830. PubMed ID: 23096712
[No Abstract] [Full Text] [Related]
15. Tubular apocrine carcinoma arising in a nevus sebaceus of Jadassohn.
Jacyk WK; Requena L; Sánchez Yus E; Judd MJ
Am J Dermatopathol; 1998 Aug; 20(4):389-92. PubMed ID: 9700379
[TBL] [Abstract][Full Text] [Related]
16. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
[TBL] [Abstract][Full Text] [Related]
17. [MAP-kinase pathway activation in nevus sebaceous and Schimmelpenning syndrome].
Dereure O
Ann Dermatol Venereol; 2013 Apr; 140(4):326-7. PubMed ID: 23567237
[No Abstract] [Full Text] [Related]
18. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
[TBL] [Abstract][Full Text] [Related]
19. Nevus Sebaceous of Jadassohn With Eight Secondary Tumors of Follicular, Sebaceous, and Sweat Gland Differentiation.
Liu Y; Valdebran M; Chen J; Elbendary A; Wu F; Xu M
Am J Dermatopathol; 2016 Nov; 38(11):861-866. PubMed ID: 27097338
[No Abstract] [Full Text] [Related]
20. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
